SPEAKER – Emergent intelligence: Accelerating the development of effective probiotic treatments
Anton learned the art of drug discovery during his 30 year tenure at Pfizer Inc, where he received several research achievement awards for his contribution to the development of pioneering pattern recognition platforms. After leaving Pfizer, he founded SystaMedic Inc where he has created new EI platforms able to analyze large volumes of multidimensional life science data. In his early career Anton worked at Nobel Prize winning labs at Harvard and ETH Zurich. He has a PhD in organic chemistry from the University of Innsbruck and a JD degree from the University of Hartford.